Hershey's CEO Claims Ozempic Breath is Driving Massive Surge in Mint and Gum Sales Across the United States
Hershey's CEO attributes an 8% sales increase in Ice Breakers mints and gum to the side effects of GLP-1 weight-loss drugs, highlighting an unexpected revenue driver.
International Business Times UK ·